Aclarion Secures Funding for CLARITY Trial of Nociscan
Aclarion Inc. (Nasdaq: ACON, ACONW) has secured nearly $20 million in gross proceeds since Jan….
Subscriber Membership Required
You must be a Subscriber member to access this content.
Already a member? Log in here
